SVAS Biosana at MARCA by BolognaFiere
SVAS Biosana participated in MARCA by BolognaFiere, producing customized medical devices and private-label products.

Svas Biosana is a medical device manufacturer and distributor.
svas.itCrawled Nov 10, 2026
SVAS Biosana participated in MARCA by BolognaFiere, producing customized medical devices and private-label products.
SVAS Biosana S.p.A. announces its board and Mark Medical S.p.A.’s board each approved a €10 million non-convertible bond issuance.
Trading of shares and warrants begins December 9, 2021.
SVAS Biosana submits application for admission to Euronext Growth Milan.
The KID for "Warrant SVAS Biosana 2021-2024" is available at the company’s legal headquarters and website.
Trading on Euronext Growth Milan begins December 9, 2021.
SVAS Biosana S.p.A., a leader in public and private healthcare, announces pre-admission to Euronext Growth Milan.
Closing price at €14.49 per share (+15.92% from offer price).
SVAS reports its consolidated revenues for the period ending March 31, 2026. The update provides financial performance metrics without additional details on specific figures or growth trends.
SVAS.it reports a material change in significant shareholders. The update involves undisclosed adjustments to ownership stakes, triggering regulatory disclosure requirements. No specific companies, individuals, or financial details are provided in the notice.
SVAS.it signs a binding acquisition agreement to acquire an unspecified target company. The deal marks a strategic move for the Italian firm to expand its operations or portfolio. Details on the acquisition terms, timeline, or the target’s identity remain undisclosed.
Italian medical equipment manufacturer **Svas Biosana** acquires **Hermes Pharma** and **Megapharm**, two Serbian distributors of medical devices. The move expands its regional footprint in the Balkans. The company finalizes both transactions as part of its growth strategy.
Italian medical appliances distributor **Svas Biosana** acquires a **75% stake in Slovenian company Bormia**, expanding its presence in the medical device sector. The agreement, announced on Tuesday, marks a strategic move for Svas Biosana to strengthen its regional footprint in Central Europe. Bormia operates as a key player in the medical appliances industry, and the acquisition aligns with Svas Biosana’s growth strategy.